CCR5Δ32, CCR2-64I, and SDF1-3′ a polymorphisms related to resistance to HIV-1 infection and disease in the Ecuadorian population

Human Biology

Volumn 77, Issue 4, 2005, Pages 521-526

  Paz Y Mino, Cesar ^a   Morillo, Santiago A ^a   Celi, Ana P ^b   Witte, Tania ^a   Guijarro, María José Muñoz ^a   Collantes, Juan Carlos ^a   Leone, Paola E ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DEL ECUADOR   (Ecuador)

^b UNIVERSIDAD DE LAS FUERZAS ARMADAS ESPE   (Ecuador)

Author keywords

CCR2 64I; CCR5 32; Chemokines; Disease prognosis; Ecuadorian population; HIV 1 infection; SDF1 3 A

Indexed keywords

CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR5; STROMAL CELL DERIVED FACTOR 1; ALPHA CHEMOKINE; CHEMOKINE RECEPTOR; MONOCYTE CHEMOATTRACTANT PROTEIN 1 RECEPTOR;

ADOLESCENT; ADULT; AGED; ALLELE; ARTICLE; CHILD; CONTROLLED STUDY; DNA POLYMORPHISM; ECUADOR; GENE FREQUENCY; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RESISTANCE; INFECTION SENSITIVITY; MAJOR CLINICAL STUDY; CHI SQUARE DISTRIBUTION; FEMALE; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; INFANT; MALE; MIDDLE AGED; POPULATION GENETICS; PRESCHOOL CHILD;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALLELES; CHEMOKINES, CXC; CHI-SQUARE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; ECUADOR; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENETICS, POPULATION; GENOTYPE; HIV INFECTIONS; HIV-1; HUMANS; INFANT; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RECEPTORS, CCR5; RECEPTORS, CHEMOKINE;

EID: 28844440084     PISSN: 00187143     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Berger, E. A., P. M. Murphy, and J. M. Farber. 1999. Chemokine receptors as HIV-1 coreceptors: Roles in viral entry, tropism, and disease. Annu. Rev. Immunol. 17:657-700.
2. Brumbilla, A., C. Villa, G. Rizzardi et al. 2000. Shorter survival of SDF1-3′A/3′A homozygotes linked to CD4+ T-cell decrease in advanced human immunodeficiency virus type 1 infection. J. Infect. Dis. 182:311-315.
3. Broder, C. C., and R. G. Collman. 1996. Chemokine receptors and HIV J. Leukocyte Biol. 1:20-29.
4. Dean, M., M. Carrington, C. Winkler et al. 1996. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Science 273:1856-1861.
5. Leboute, A. P., M. W. Carvalho, and A. L. Simoes. 1999. Absence of the CCR5D32 mutation in indigenous populations of the Brazilian Amazon. Hum. Genet. 105:442-443
6. Levy, J. A. 1996. Infection by human immunodeficiency virus: CD4 is not enough. New Engl. J. Med. 335:1528-1530.
7. Liu, R., W. A. Paxton, S. Choe et al. 1996. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 86:367-377.
8. Magierowska, M., V. Lepage, L. Boubnova et al. 1998. Distribution of the CCR5 gene 32 base pair deletion and SDF1-3′A variant in healthy individuals from different populations. Immunogenetica 48:417-419.
9. Magierowska, M., I. Theodorou, P. Debre et al. 1999. Combined genotypes of CCR5, CCR2, SDF1, and HLA genes can predict the long-term nonprogressor status in human immunodeficiency virus-1 infected individuals. Blood 93:936-941.
10. Martinson, J. J., N. H. Chapman, D. C. Rees et al. 1997. Global distribution of the CCR5 gene 32-base pair deletion. Nat. Genet. 16:100-103.
11. McNicholl, J. M., D. K. Smith, S. H. Qari et al. 1997. Host genes and HIV: The role of the chemokine receptor gene CCR5 and its allele (Δ32 CCR5). Emerg. Infect. Dis. 3:261-271.
12. Miller, S. A., D. D. Dykes, and H. F. Polesky. 1988. A simple salting-out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16:1215.
13. Mummidi, S., S. S. Ahuja, E. Gonzalez et al. 1998. Genealogy of the CCR5 locus and chemokine system gene variants associated with altered rates of HIV-1 disease progression. Nat. Med. 4:786-793.
14. Paz-y-Miño, C. 1998. Ecuador: Medical genetic services in Latin America-The case of Ecuador. In Medical Genetics Services in Latin America, V. Penchaszadeh, ed. New York: World Health Organization, Human Genetics Program, 14-16.
15. Rugeles, M. T., F. J. Díaz, J. A. Vega et al. 2001. Frecuencia de mutaciones en el coreceptor CCR5 del Virus de la Inmunodeficiencia Humana (VIH) en diferentes grupos en Medellín, Colombia. Infectio 2:3-17.
16. Samson, M., F. Libert, B. J. Doranz et al. 1996. Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 382:722-725.
17. Smith, M. W., M. Dean, M. Carrington et al. 1997. Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Science 277:959-965.
18. Stephens, J. C., H. D. Shin, M. W. Smith et al. 1998. Dating the origin of the CCR5-32 AIDS-resistance allele by the coalescence of haplotypes. Am. J. Hum. Genet 62:1507-1515.
19. Su, B., L. Jin, F. Hu et al. 1999. Distribution of two HIV-1 resistant polymorphisms (SDF1-3′A and CCR2-64I) in East Asia and world populations and its implication in AIDS epidemiology. Am. J. Hum. Genet. 65:1047-1053.
20. van Rij, R. P., S. Broersen, J. Goudsmit et al. 1998. The role of a stromal cell-derived-factor-1 chemokine gene variant in the clinical course of HIV-1 infection. AIDS 12:85-90.
21. Williamson, C., S. A. Loubser, B. Brice et al. 2000. Allelic frequencies of host genetic variants influencing susceptibility to HIV-1 infection and disease in South African populations. AIDS 14:449-451.
22. Winkler, C., W. Modi, M. W. Smith et al. 1998. Genetic restriction of AIDS pathogenesis by an SDF-1 chemokine gene variant. Science 279:389-393.
23. Yudin, N. S., S. V. Vinogradov, T. A. Potapova et al. 1998. Distribution of CCR5-delta 32 gene deletion across the Russian part of Eurasia. Hum. Genet. 102:695-698.